Stuttgart - Delayed Quote EUR

Pacific Biosciences of California Inc (P09.SG)

Compare
1.5986
+0.0384
+(2.46%)
At close: January 17 at 7:42:15 PM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-232,968.0000
-259,173.0000
-263,211.0000
-111,180.0000
19,503.0000
Investing Cash Flow
-809.0000
4,604.0000
116,083.0000
-678,531.0000
-219,322.0000
Financing Cash Flow
-74,389.0000
108,891.0000
9,622.0000
1,169,581.0000
251,839.0000
End Cash Position
80,204.0000
179,911.0000
325,089.0000
460,725.0000
85,947.0000
Interest Paid Supplemental Data
--
15,687.0000
14,049.0000
6,928.0000
491.0000
Capital Expenditure
-6,595.0000
-8,843.0000
-16,929.0000
-5,931.0000
-1,039.0000
Issuance of Capital Stock
--
189,200.0000
--
294,845.0000
187,479.0000
Issuance of Debt
--
--
--
895,536.0000
--
Repayment of Debt
-935.0000
-1,842.0000
-1,608.0000
-361.0000
-16,000.0000
Free Cash Flow
-239,563.0000
-268,016.0000
-280,140.0000
-117,111.0000
18,464.0000
12/31/2020 - 7/24/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers